or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    MRKR D Marker Therapeutics, Inc. 5.02
    CASI D CASI Pharmaceuticals, Inc. -2.86
    PSTX D Poseida Therapeutics, Inc. 0.74
    SLS D SELLAS Life Sciences Group, Inc. -4.10
    CERO D CERo Therapeutics Holdings, Inc. -12.02
    CLDI D Calidi Biotherapeutics, Inc. -0.47
    INAB D IN8bio, Inc. -0.75
    KYMR D Kymera Therapeutics, Inc. 3.38
    GTBP D GT Biopharma, Inc. 1.66
    ANIX D Anixa Biosciences, Inc. 4.58
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Cancer Biotechnology Cancer Treatment Clinical Medicine Immune System Medicine Biopharmaceutical Treatment Of Cancer Cancer Immunotherapy Cell Therapy Hematological Malignancies Leukemia Life Sciences Ovarian Cancer Tumor Virotherapy Autoimmune Disease Chimeric Antigen Receptor Hematologic Malignancies Immunology

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 2.11
    CANC F Tema Oncology ETF 1.52
    BBC F Virtus LifeSci Biotech Clinical Trials ETF 1.25
    LRNZ A TrueMark Technology, AI & Deep Learning ETF 0.8
    XBI D SPDR S&P Biotech ETF 0.39
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare CNCR to BBC Compare CNCR to XBI Compare LRNZ to XBI

        Solid Tumors Stocks Recent News

        Date Stock Title
        Nov 22 ANIX Anixa rises as board approves Bitcoin as a treasury reserve asset
        Nov 22 ANIX Anixa Biosciences board approves purchase of Bitcoin as treasury reserve asset
        Nov 18 ANIX Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
        Nov 17 MRKR Marker Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 17 CASI CASI Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
        Nov 16 SLS We're A Little Worried About SELLAS Life Sciences Group's (NASDAQ:SLS) Cash Burn Rate
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Cancer Clinical Medicine Medicine Advanced Solid Tumors Oncology Acute Myeloid Leukemia Biopharmaceutical Cancer Immunotherapy Cancer Treatment Immune System Tumors Of The Hematopoietic And Lymphoid Tissues Antineoplastic Drugs Biotechnology Chemotherapy Drugs Hematologic Malignancies Hematological Malignancies Immunology Immunotherapy Lymphoma
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags